Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Shares Outstanding (Weighted Average) (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $92.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 82.89% year-over-year to $92.1 million, compared with a TTM value of $92.1 million through Sep 2025, up 82.89%, and an annual FY2024 reading of $50.5 million, up 20.98% over the prior year.
  • Shares Outstanding (Weighted Average) was $92.1 million for Q3 2025 at Lucid Diagnostics, up from $84.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $92.1 million in Q3 2025 and bottomed at $14.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $42.5 million, with a median of $41.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) surged 153.41% in 2022, then grew 9.87% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $18.6 million in 2021, then surged by 94.44% to $36.2 million in 2022, then grew by 15.44% to $41.8 million in 2023, then increased by 20.98% to $50.5 million in 2024, then soared by 82.38% to $92.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for LUCD at $92.1 million in Q3 2025, $84.0 million in Q2 2025, and $68.8 million in Q1 2025.